Accuracy of five on-site immunoassay drugs-of-abuse testing devices

被引：25

作者：

Taylor, EH

Oertli, EH

Wolfgang, JW

Mueller, E

机构：

[1] Natl Safety Alliance, Nashville, TN 37211 USA

[2] Lab Specialists Inc, Gretna, LA 70053 USA

来源：

JOURNAL OF ANALYTICAL TOXICOLOGY | 1999年 / 23卷 / 02期

关键词：

D O I：

10.1093/jat/23.2.119

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

Many current 'on-site' urine drug-testing products claim performance equivalent to laboratory testing. Five commercially available products (PharmScreen(TM), Roche TestCup®, Accusign(TM) DOA 2, Status DS(TM), and American Bio Medica-Rapid Drug Screen) were challenged with quality-control specimens of known drug metabolite concentrations, 25% above and 25% below the SAMHSA cutoffs, and with known positive and negative donor specimens previously analyzed by immunoassay and gas chromatography-mass spectrometry. The results indicate discrepancies between claims and performance for all products, particularly with amphetamines. The implications for employer- based drug testing are discussed.

引用

页码：119 / 124

页数：6

共 17 条

[11]

*PRINC BIOM, 1996, ACC DOA 2 PACK INS R

[12]

*ROCH DIAGN SYST, 1997, ROCH TESTC PACK INS

[13] APPLICATION OF THE NOVEL IMMUNOASSAY TRIAGE(TM) TO A RAPID DETECTION OF ANTEMORTEM DRUG-ABUSE [J].